Shanghai Haohai Biological Technology Co., Ltd. (6826.HK)

HKD 26.85

(-1.65%)

Long Term Debt Summary of Shanghai Haohai Biological Technology Co., Ltd.

Shanghai Haohai Biological Technology Co., Ltd.'s latest annual long term debt in 2023 was 191.32 Million CNY , up 128.09% from previous year.
Shanghai Haohai Biological Technology Co., Ltd.'s latest quarterly long term debt in 2024 Q1 was 202.82 Million CNY , up 9.76% from previous quarter.
Shanghai Haohai Biological Technology Co., Ltd. reported annual long term debt of 83.88 Million CNY in 2022, up 112.39% from previous year.
Shanghai Haohai Biological Technology Co., Ltd. reported annual long term debt of 39.49 Million CNY in 2021, up 93.85% from previous year.
Shanghai Haohai Biological Technology Co., Ltd. reported quarterly long term debt of 202.82 Million CNY for 2024 Q1, up 9.76% from previous quarter.
Shanghai Haohai Biological Technology Co., Ltd. reported quarterly long term debt of 265 Million CNY for 2023 Q3, up 48.21% from previous quarter.

Annual Long Term Debt Chart of Shanghai Haohai Biological Technology Co., Ltd. (2023 - 2012)

Historical Annual Long Term Debt of Shanghai Haohai Biological Technology Co., Ltd. (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	191.32 Million CNY	128.09%
2022	83.88 Million CNY	112.39%
2021	39.49 Million CNY	93.85%
2020	20.37 Million CNY	-15.12%
2019	24 Million CNY	46.48%
2018	16.38 Million CNY	-6.88%
2017	17.59 Million CNY	0.0%
2016	- CNY	0.0%
2015	- CNY	0.0%
2014	- CNY	0.0%
2013	- CNY	0.0%
2012	- CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	193.19 Million CNY	-3.14%
2024 Q1	202.82 Million CNY	9.76%
2023 Q3	265 Million CNY	48.21%
2023 FY	191.32 Million CNY	128.09%
2023 Q1	178.8 Million CNY	113.17%
2023 Q2	178.8 Million CNY	0.0%
2023 Q4	191.32 Million CNY	-27.8%
2022 Q4	83.88 Million CNY	90.72%
2022 Q3	43.98 Million CNY	29.37%
2022 Q2	33.99 Million CNY	0.0%
2022 Q1	33.99 Million CNY	-13.92%
2022 FY	83.88 Million CNY	112.39%
2021 Q1	17.84 Million CNY	-12.41%
2021 Q2	17.84 Million CNY	0.0%
2021 Q3	52.74 Million CNY	195.58%
2021 Q4	39.49 Million CNY	-25.13%
2021 FY	39.49 Million CNY	93.85%
2020 Q3	26.39 Million CNY	-17.72%
2020 FY	20.37 Million CNY	-15.12%
2020 Q1	- CNY	-100.0%
2020 Q4	20.37 Million CNY	-22.81%
2020 Q2	32.07 Million CNY	0.0%
2019 Q4	24 Million CNY	0.0%
2019 FY	24 Million CNY	46.48%
2019 Q2	41.95 Million CNY	0.0%
2019 Q1	- CNY	-100.0%
2018 Q2	17.46 Million CNY	0.0%
2018 Q4	16.38 Million CNY	0.0%
2018 Q1	17.46 Million CNY	-0.74%
2018 Q3	16.38 Million CNY	-6.18%
2018 FY	16.38 Million CNY	-6.88%
2017 Q3	17.59 Million CNY	-2.78%
2017 FY	17.59 Million CNY	0.0%
2017 Q1	18.1 Million CNY	0.0%
2017 Q2	18.1 Million CNY	0.0%
2017 Q4	17.59 Million CNY	0.0%
2016 Q1	- CNY	0.0%
2016 Q3	- CNY	0.0%
2016 Q2	- CNY	0.0%
2016 FY	- CNY	0.0%
2016 Q4	- CNY	0.0%
2015 Q3	- CNY	0.0%
2015 Q2	- CNY	0.0%
2015 Q1	- CNY	0.0%
2015 FY	- CNY	0.0%
2015 Q4	- CNY	0.0%
2014 Q1	- CNY	0.0%
2014 FY	- CNY	0.0%
2014 Q3	- CNY	0.0%
2014 Q2	- CNY	0.0%
2014 Q4	- CNY	0.0%
2013 Q3	- CNY	0.0%
2013 Q4	- CNY	0.0%
2013 Q1	- CNY	0.0%
2013 FY	- CNY	0.0%
2012 FY	- CNY	0.0%

Peer Long Term Debt Comparison of Shanghai Haohai Biological Technology Co., Ltd.

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	-524.997%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	95.522%